Hyperlipidemia and graft loss

Transplantation Proceedings

Volumn 34, Issue 6, 2002, Pages 2423-2425

  Stephan, A ^a   Barbari, A ^a   Karam, A ^a   Kilani, H ^a   Kamel, G ^a   Masri, A M ^a  

^a RIZK HOSPITAL   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CYCLOSPORIN A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RAPAMYCIN; STATIN; STEROID;

ATHEROSCLEROSIS; CANCER; CAUSE OF DEATH; CHRONIC GRAFT REJECTION; CONFERENCE PAPER; DISEASE COURSE; DRUG EFFECT; DRUG METABOLISM; DRUG SAFETY; GRAFT SURVIVAL; HUMAN; HYPERLIPIDEMIA; IMMUNOMODULATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER FAILURE; NEPHROTIC SYNDROME; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SEPSIS; SIDE EFFECT; SURGICAL MORTALITY; TREATMENT OUTCOME; UREMIA; VASCULAR DISEASE;

ANTILIPEMIC AGENTS; ARTERIOSCLEROSIS; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT FAILURE; VASCULAR DISEASES;

EID: 0036755245     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(02)03163-9     Document Type: Conference Paper

References (30)

1. Rao V.K. Surg Clin North Am. 78:1998;113.
2. Fellstrom B. Presse Med. 26:1997;S26.
3. Vaziri N.D., Liang K., Azad H. J Pharmacol Exp Ther. 294:2000;778.
4. Freiman S., et al. Transplant Proc. 3:1999;S41.
5. Grundy S.M. Kidney Int. 37:1990;847.
6. Ross R. N Engl J Med. 340:1999;115.
7. Packard CJ: Eur Heart J 1.S:T2, 1999.
8. Gotto A.M. Jr, et al. Am J Med. 104:1998;6S.
9. Isoniemi H., Nurminen M., Tikkanen M.J., et al. Transplantation. 57:1994;68.
10. Weiss M., et al. Circulation. 96:1997;2069.
11. Droz D, Lantz et al: La Biopsie Réna: 578, 1996.
12. Scheuer H., Gwinner W., Hohbach J., et al. Am J Physiol Renal Physiol. 278:2000;F63.
13. Fuiano et al: Nephron; 108:420, 1996.
14. Keane WF, Wien Klin, et al:Wochenschr 108:420, 1996.
15. Knopp R.H. N Engl J Med. 341:1999;498.
16. Fellstrom B. Transplantation. 70:2000;S51.
17. Katzenelson S., Kobashigawa J.A. Kidney Int. 48:1995;S112.
18. Wanner C., Quaschning T., Weingarnter K. Curr Opin Urol. 10:2000;77.
19. Dresser G.K., Spence J.D., Bailey D.G. Clin Pharmacokinet. 38:2000;41.
20. Horsmans Y., et al. Eur Heart J. 1:1999;T7.
21. Valentine H.A., et al. Circulation. 96:1997;1370.
22. Jardine A., Hoidaas H., et al. J Clin Pharm Ther. 24:1999;397.
23. Kim S. Kidney Int. 58:2000;S88.
24. Bankhurst A.D., Cutts L.J., et al. J Cell Physiol. 145:1990;244.
25. Cutts L.J., Scallen T.J., Watson J., et al. J Cell Physiol. 139:1989;550.
26. Doyle J.W., Kandutsch A.A., et al. J Cell Physiol. 137:1988;133.
27. Kreuzer J., et al. Atherosclerosis. 90:1990;203.
28. McPherson R., Tsoukas C., Baines M.G., et al. J Clin Immunol. 13:1993;439.
29. Krenzer et al:Atherosclerosis 90:203, 1991.
30. Ozdemir FN, Haberal M, et al: (in press).